REG - GSK PLC - Result of AGM

GSKAnnouncement

08/05/2024 18:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240508:nRSH6940Na&default-theme=true

RNS Number : 6940N  GSK PLC  08 May 2024

GSK plc

 

Results of 24(th) Annual General Meeting

 

GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on
Wednesday 8 May 2024 at the Royal Lancaster London, Lancaster Terrace, London,
W2 2TY. Shareholders were able to join the meeting in person or virtually via
the Lumi AGM website.

 

All valid proxy votes (whether submitted electronically or in hard copy form)
were included in the poll taken at the meeting.

 

The table below shows the results of the poll on all 23 resolutions. The full
text of the resolutions is contained in the Notice of AGM published on 25
March 2024, which is available on GSK's website at www.gsk.com
(http://www.gsk.com) .

 

 Resolution                                                                           Total votes for((1)(2))  %      Total votes against((2))  %     Total votes cast  Votes withheld((3))
 1       Receive and adopt the 2023 Annual Report                                     3,026,657,634            99.93  1,985,899                 0.07  3,028,643,533     11,560,313
 2       Approve the Annual report on remuneration                                    2,782,337,600            92.70  219,140,461               7.30  3,001,478,061     38,693,019
 3       Election of Wendy Becker                                                     2,908,153,080            95.87  125,392,399               4.13  3,033,545,479     6,609,293
 4       Election od Dr Jeannie Lee                                                   3,029,569,885            99.87  4,058,143                 0.13  3,033,628,028     6,567,803
 5       Re-election of Sir Jonathan Symonds                                          3,018,694,064            99.51  14,982,162                0.49  3,033,676,226     6,516,614
 6       Re-election of Dame Emma Walmsley                                            3,028,232,685            99.81  5,822,706                 0.19  3,034,055,391     6,142,099
 7       Re-election of Julie Brown                                                   3,024,167,039            99.68  9,628,961                 0.32  3,033,796,000     6,386,918
 8       Re-election of Elizabeth McKee Anderson                                      2,960,185,482            97.57  73,605,787                2.43  3,033,791,269     6,404,117
 9       Re-election of Charles Bancroft                                              3,019,529,985            99.54  13,986,857                0.46  3,033,516,842     6,668,927
 10      Re-election of Dr Hal Barron                                                 3,022,032,114            99.61  11,790,927                0.39  3,033,823,041     6,360,307
 11      Re-election of Dr Anne Beal                                                  3,021,808,961            99.60  12,038,342                0.40  3,033,847,303     6,336,638
 12      Re-election of Dr Harry C Dietz                                              3,029,031,724            99.85  4,650,326                 0.15  3,033,682,050     6,508,974
 13      Re-election of Dr Jesse Goodman                                              3,028,663,561            99.84  4,930,361                 0.16  3,033,593,922     6,598,956
 14      Re-election of Dr Vishal Sikka                                               2,868,354,507            94.57  164,801,089               5.43  3,033,155,596     7,017,053
 15      Re-appointment of the auditor                                                3,014,623,759            99.95  1,608,077                 0.05  3,016,231,836     23,950,717
 16      Remuneration of the auditor                                                  3,031,902,105            99.92  2,552,472                 0.08  3,034,454,577     5,710,703
 17      Authority for the company to make donations to political organisations and   2,932,886,023            98.76  36,920,830                1.24  2,969,806,853     70,418,813
         incur political expenditure
 18      Authority to allot shares                                                    2,902,088,897            95.68  130,945,918               4.32  3,033,034,815     7,163,455
 19      Disapplication of pre-emption rights - general power((4))                    2,961,493,840            97.71  69,555,193                2.29  3,031,049,033     9,105,429
 20      Disapplication of pre-emption rights - in connection with an acquisition or  2,937,510,909            96.91  93,802,022                3.09  3,031,312,931     8,843,231
         specified capital investment((4))
 21      Authority for the company to purchase its own shares((4))                    3,007,905,874            99.25  22,735,155                0.75  3,030,641,029     9,526,430
 22      Exemption from statement of senior statutory auditor's name                  2,960,435,195            99.72  8,381,561                 0.28  2,968,816,756     71,372,939
 23      Authority for reduced notice of a general meeting other than an AGM((4))     2,795,236,350            93.79  185,233,215               6.21  2,980,469,565     59,729,307

 

 

Notes:

 

(1)      The "for" votes include those giving the Chair discretion.

(2)      Votes "for" and "against" are expressed as a percentage of the
total votes cast.

(3)      A "vote withheld" is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a resolution.

(4)      Indicates Special Resolutions requiring a 75% majority of votes
cast.

 

The Company's issued share capital as at 3 May 2024 consisted of 4,144,937,355
shares of 31 ¼ pence each ('Ordinary Shares') excluding Ordinary Shares held
in Treasury. Every shareholder has one vote for every Ordinary Share held.

 

The above poll results will shortly be available on the company's website at
www.gsk.com (http://www.gsk.com) .

 

In accordance with Listing Rule 9.6.2 of the Financial Conduct Authority's
(FCA) Listing Rules, a copy of the resolutions, other than those concerning
ordinary business, will be submitted to the FCA and will in due course be
available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 

V A Whyte

Company Secretary

8 May 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGAPMRTMTTMBMI